Last reviewed · How we verify

NCT07073664

A Study Evaluating the Efficacy of Endoscope Ethmoid Infundibulum Expansion Surgery (EEIES) Combined With Stapokibart in the Treatment of Type 2 Chronic Rhinosinusitis

ENROLLING BY INVITATION NA Last updated 24 July 2025
What this trial tests

NA trial testing The surgical side of Endoscope Ethmoid Infundibulum Expansion Surgery (EEIES) in Chronic Sinusitis in 30 participants. Enrolling by invitation.

Timeline
21 April 2025
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorChina-Japan Union Hospital
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingdouble
Primary purposetreatment
Enrollment30
Start date21 April 2025
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

China-Japan Union Hospital

Who can join

Adults 18 to 75, any sex, with Chronic Sinusitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Through a prospective study, the efficacy of Endoscope Ethmoid Infundibulum Expansion Surgery (EEIES) in the surgical treatment of patients with type 2 chronic rhinosinusitis was verified. The aim was to provide evidence-based medical evidence for the effectiveness of local minimally invasive surgery combined with biologics in the treatment of type 2 chronic rhinosinusitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other China-Japan Union Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07073664.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing